Liminatus Pharma, Inc.

LIMN, LIMNW · CIK 0001971387 · operating

$0.09+23.01%Last updated Mar 2, 8:48 PM

OverviewFinancial Statements Valuation Models

Key Statistics

Valuation

Market Cap—

P/E—

Fwd P/E—

PEG—

P/S—

P/B—

EV/EBITDA—

EV/Rev—

Profitability

Gross Margin—

Op. Margin—

Net Margin—

ROE—

ROA—

FCF Margin—

Financial Health

Current Ratio—

Debt/Equity—

Free Cash Flow—

Div. Yield—

Growth & Other

Revenue Growth—

EPS Growth—

Beta0.50

52W High$0.085

52W Low$0.085

About Liminatus Pharma, Inc.

Liminatus Pharma, Inc. (LIMNW) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. The stock currently trades at $0.09, up 23.01% today, with a 52-week range of $0.06–$0.07.

Latest News

Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public OfferingYahoo Finance · Feb 17, 2026
BC-Most Active StocksYahoo Finance · Feb 9, 2026
Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic CooperationYahoo Finance · Oct 30, 2025
BNB Falls Below $750 as Crypto Market Sell-Off Erases Corporate-Fueled Optimismcoindesk.com · Aug 5, 2025
Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment Vehicle Targeting Up To $500 Million in Capital StrategiesYahoo Finance · Jul 25, 2025
Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital StrategyYahoo Finance · Jul 24, 2025
Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury StrategyYahoo Finance · Jul 22, 2025

Annual Reports (10-K) · 0 filings

No 10-K filings found.